Literature DB >> 2267199

Antiphospholipid antibodies: which and when?

R Cervera, J Font, M A Khamashta, G R Hughes.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2267199      PMCID： PMC2429760          DOI： 10.1136/pgmj.66.781.889

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  32 in total

1.  Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

Authors:  R Cervera; J Font; A López-Soto; F Casals; L Pallarés; A Bové; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

2.  Antiphospholipid antibodies in unselected patients with repeated abortion.

Authors:  J Balasch; J Font; A López-Soto; R Cervera; I Jové; F J Casals; J A Vanrell
Journal:  Hum Reprod       Date:  1990-01       Impact factor: 6.918

3.  Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies.

Authors:  C Lavalle; S Pizarro; C Drenkard; J Sánchez-Guerrero; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1990-01       Impact factor: 4.666

4.  Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant.

Authors:  D Green; C Hougie; F J Kazmier; K Lechner; P M Mannucci; C R Rizza; Y Sultan
Journal:  Thromb Haemost       Date:  1983-04-28       Impact factor: 5.249

5.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

6.  Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations.

Authors:  J Font; R Cervera; A Lopez-Soto; L Pallares; X Bosch; S Ampurdanes; F J Casals; M Ingelmo
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

7.  The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors:  R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

8.  Thrombosis in patients with the lupus anticoagulant.

Authors:  J R Mueh; K D Herbst; S I Rapaport
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

9.  Fetal survival after prednisone suppression of maternal lupus-anticoagulant.

Authors:  W F Lubbe; W S Butler; S J Palmer; G C Liggins
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

10.  Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus.

Authors:  M A Khamashta; R Cervera; R A Asherson; J Font; A Gil; D J Coltart; J J Vázquez; C Paré; M Ingelmo; J Oliver
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321
View more
  2 in total

Review 1.  Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion.

Authors:  M A Khamashta; G R Hughes
Journal:  Clin Rev Allergy       Date:  1994

Review 2.  An acquired-pseudo Bernard Soulier syndrome occurring with autoimmune chronic active hepatitis and anti-cardiolipin antibody.

Authors:  I L Beales
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.